Correction to: PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors

Affiliations

¹ Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. juquint@email.unc.edu.
² Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³ Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁴ Bayer Health Care Pharmaceuticals, Whippany, NJ, USA.
⁵ Department of Medicine, The University of Chicago, Chicago, IL, USA.
⁶ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
⁷ Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
⁸ Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. federico.innocenti@abbvie.com.

Published Erratum

Julia C F Quintanilha et al. Pharmacogenomics J. 2022 Mar.

. 2022 Mar;22(2):145.

doi: 10.1038/s41397-021-00264-2.

¹ Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. juquint@email.unc.edu.
² Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³ Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁴ Bayer Health Care Pharmaceuticals, Whippany, NJ, USA.
⁵ Department of Medicine, The University of Chicago, Chicago, IL, USA.
⁶ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
⁷ Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
⁸ Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. federico.innocenti@abbvie.com.

No abstract available

Erratum for

PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors.
Quintanilha JCF, Racioppi A, Wang J, Etheridge AS, Denning S, Peña CE, Skol AD, Crona DJ, Lin D, Innocenti F. Quintanilha JCF, et al. Pharmacogenomics J. 2022 Feb;22(1):82-88. doi: 10.1038/s41397-021-00261-5. Epub 2021 Nov 13. Pharmacogenomics J. 2022. PMID: 34775477 Free PMC article.